D. E. Shaw & Co »

Acrivon Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $157k 32k 4.92
2023-09-30 $447k 47k 9.56
2023-06-30 $608k 47k 12.96
2023-03-31 $786k 62k 12.69

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Acrivon Therapeutics

RA Capital Management
Perceptive Advisors
Citadel Advisors
Wellington Management Company
Marshall Wace
Vanguard Group
NEA Management Company
Federated Investors
DAFNA Capital Management
Charles Schwab Investment Management
Exchange Traded Concepts
Jacobs Levy Equity Management
Jpmorgan Chase & Co
D. E. Shaw & Co
Barclays

View all funds holding Acrivon Therapeutics